We're sorry, but BRENDA doesn't work properly without JavaScript. Please make sure you have JavaScript enabled in your browser settings.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
IUBMB Comments The enzymes from rat liver and bovine liver act on both enantiomers of 4-hydroxy-2-oxoglutarate. cf. EC 4.1.3.42, (4S)-4-hydroxy-2-oxoglutarate aldolase.
The taxonomic range for the selected organisms is: Homo sapiens The expected taxonomic range for this enzyme is: Eukaryota, Bacteria, Archaea
Synonyms
hoga1, 4-hydroxy-2-oxoglutarate aldolase, 2-keto-4-hydroxyglutarate aldolase, 2-oxo-4-hydroxyglutarate aldolase, dhdpsl, 4-hydroxy-2-ketoglutarate aldolase, entner-doudoroff aldolase, dihydrodipicolinate synthase-like enzyme,
more
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-hydroxy-2-oxoglutarate aldolase
-
dihydrodipicolinate synthase-like enzyme
-
2-keto-4-hydroxybutyrate aldolase
-
-
-
-
2-keto-4-hydroxyglutarate aldolase
-
-
-
-
2-keto-4-hydroxyglutaric aldolase
-
-
-
-
2-oxo-4-hydroxyglutarate aldolase
-
-
-
-
2-oxo-4-hydroxyglutaric aldolase
-
-
-
-
4-hydroxy-2-ketoglutarate aldolase
-
-
-
-
4-hydroxy-2-ketoglutaric aldolase
-
-
-
-
aldolase, 4-hydroxy-2-oxoglutarate
-
-
-
-
DL-4-Hydroxy-2-ketoglutarate aldolase
-
-
-
-
hydroxyketoglutarate aldolase
-
-
-
-
Hydroxyketoglutaric aldolase
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-hydroxy-2-oxoglutarate glyoxylate-lyase (pyruvate-forming)
The enzymes from rat liver and bovine liver act on both enantiomers of 4-hydroxy-2-oxoglutarate. cf. EC 4.1.3.42, (4S)-4-hydroxy-2-oxoglutarate aldolase.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-Hydroxy-2-oxoglutarate
Pyruvate + glyoxylate
4-Hydroxy-2-oxoglutarate
Pyruvate + glyoxylate
-
-
-
-
?
additional information
?
-
4-Hydroxy-2-oxoglutarate
Pyruvate + glyoxylate
-
-
-
?
4-Hydroxy-2-oxoglutarate
Pyruvate + glyoxylate
-
-
-
r
4-Hydroxy-2-oxoglutarate
Pyruvate + glyoxylate
-
-
-
-
r
additional information
?
-
enzyme performs a retro-aldol cleavage reaction reminiscent of the trimeric 2-keto-3-deoxy-6-phosphogluconate aldolases
-
-
?
additional information
?
-
-
enzyme performs a retro-aldol cleavage reaction reminiscent of the trimeric 2-keto-3-deoxy-6-phosphogluconate aldolases
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-Hydroxy-2-oxoglutarate
Pyruvate + glyoxylate
-
-
-
?
4-Hydroxy-2-oxoglutarate
Pyruvate + glyoxylate
-
-
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-hydroxy-2-oxoglutarate aldolase deficiency
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.
4-hydroxy-2-oxoglutarate aldolase deficiency
Primary hyperoxaluria type III-a model for studying perturbations in glyoxylate metabolism.
Hyperoxaluria
Mutations in HOGA1 do Not Confer a Dominant Phenotype Manifesting as Kidney Stone Disease.
Hyperoxaluria
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.
Hyperoxaluria, Primary
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.
Hyperoxaluria, Primary
Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3.
Hyperoxaluria, Primary
Clinical characterization of primary hyperoxaluria type 3 in comparison to types 1 and 2: a retrospective cohort study.
Hyperoxaluria, Primary
Dihydrodipicolinate Synthase: Structure, Dynamics, Function, and Evolution.
Hyperoxaluria, Primary
Folding Defects Leading to Primary Hyperoxaluria.
Hyperoxaluria, Primary
HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.
Hyperoxaluria, Primary
Hydroxyproline metabolism in a mouse model of Primary Hyperoxaluria Type 3.
Hyperoxaluria, Primary
Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.
Hyperoxaluria, Primary
Mutations in DHDPSL are responsible for primary hyperoxaluria type III.
Hyperoxaluria, Primary
Mutations in HOGA1 do Not Confer a Dominant Phenotype Manifesting as Kidney Stone Disease.
Hyperoxaluria, Primary
Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.
Hyperoxaluria, Primary
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.
Hyperoxaluria, Primary
Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencing.
Hyperoxaluria, Primary
Possible ethnic associations in primary hyperoxaluria type-III-associated HOGA1 sequence variants.
Hyperoxaluria, Primary
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
Hyperoxaluria, Primary
Primary hyperoxaluria type III-a model for studying perturbations in glyoxylate metabolism.
Hyperoxaluria, Primary
Re: Mutations in DHDPSL are Responsible for Primary Hyperoxaluria Type III.
Hyperoxaluria, Primary
Re: primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
Hyperoxaluria, Primary
Regulation of human 4-hydroxy-2-oxoglutarate aldolase by pyruvate and ?-ketoglutarate: implications for primary hyperoxaluria type-3.
Hyperoxaluria, Primary
Renal function can be impaired in children with primary hyperoxaluria type 3.
Hyperoxaluria, Primary
Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria.
Hyperoxaluria, Primary
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.
Hyperoxaluria, Primary
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type III.
Hyperoxaluria, Primary
Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3.
Hyperoxaluria, Primary
[Genetic aspects of primary hyperoxaluria: epidemiology, ethiology, pathogenesis, and clinical signs of the disorder].
Kidney Calculi
Mutations in HOGA1 do Not Confer a Dominant Phenotype Manifesting as Kidney Stone Disease.
Urolithiasis
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
Urolithiasis
Re: primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.008 - 0.281
4-hydroxy-2-oxoglutarate
0.008
4-hydroxy-2-oxoglutarate
mutant Y140F, pH 8.5, 37°C
0.011
4-hydroxy-2-oxoglutarate
wild-type, pH 8.5, 37°C
0.016
4-hydroxy-2-oxoglutarate
mutant N78T, pH 8.5, 37°C
0.044
4-hydroxy-2-oxoglutarate
mutant S198A, pH 8.5, 37°C
0.058
4-hydroxy-2-oxoglutarate
mutant S77T, pH 8.5, 37°C
0.066
4-hydroxy-2-oxoglutarate
mutant N78A, pH 8.5, 37°C
0.077
4-hydroxy-2-oxoglutarate
mutant S198T, pH 8.5, 37°C
0.082
4-hydroxy-2-oxoglutarate
mutant S77V, pH 8.5, 37°C
0.084
4-hydroxy-2-oxoglutarate
mutant S77A, pH 8.5, 37°C
0.281
4-hydroxy-2-oxoglutarate
mutant N78Q, pH 8.5, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.8 - 7.8
4-hydroxy-2-oxoglutarate
0.8
4-hydroxy-2-oxoglutarate
mutant S77T, pH 8.5, 37°C
1.2
4-hydroxy-2-oxoglutarate
mutant S77V, pH 8.5, 37°C
2.4
4-hydroxy-2-oxoglutarate
mutant S198A, pH 8.5, 37°C
2.5
4-hydroxy-2-oxoglutarate
mutant S77A, pH 8.5, 37°C
4
4-hydroxy-2-oxoglutarate
mutant N78T, pH 8.5, 37°C
5.2
4-hydroxy-2-oxoglutarate
mutant Y140F, pH 8.5, 37°C
6.1
4-hydroxy-2-oxoglutarate
wild-type, pH 8.5, 37°C
6.2
4-hydroxy-2-oxoglutarate
mutant N78Q, pH 8.5, 37°C
7.6
4-hydroxy-2-oxoglutarate
mutant N78A, pH 8.5, 37°C
7.8
4-hydroxy-2-oxoglutarate
mutant S198T, pH 8.5, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
14 - 650
4-hydroxy-2-oxoglutarate
14
4-hydroxy-2-oxoglutarate
mutant S77T, pH 8.5, 37°C
15
4-hydroxy-2-oxoglutarate
mutant S77V, pH 8.5, 37°C
22
4-hydroxy-2-oxoglutarate
mutant N78Q, pH 8.5, 37°C
30
4-hydroxy-2-oxoglutarate
mutant S77A, pH 8.5, 37°C
55
4-hydroxy-2-oxoglutarate
mutant S198A, pH 8.5, 37°C
101
4-hydroxy-2-oxoglutarate
mutant S198T, pH 8.5, 37°C
115
4-hydroxy-2-oxoglutarate
mutant N78A, pH 8.5, 37°C
250
4-hydroxy-2-oxoglutarate
mutant N78T, pH 8.5, 37°C
555
4-hydroxy-2-oxoglutarate
wild-type, pH 8.5, 37°C
650
4-hydroxy-2-oxoglutarate
mutant Y140F, pH 8.5, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
SwissProt
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
malfunction
-
primary hyperoxaluria type 3 is due to mutations in the 4-hydroxy-2-oxoglutarate aldolase gene
malfunction
mutations are responsible for primary hyperoxaluria type III
malfunction
enzyme deficiency leads to primary hyperoxaluria type 3
malfunction
enzyme mutations ultimately lead to oxalate accumulation and stone formation in primary hyperoxaluria type 3
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
HOGA1_HUMAN
327
0
35249
Swiss-Prot
Mitochondrion (Reliability: 2 )
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
97200
sedimentation equilibrium centrifugation
35249
4 * 35249, calculated
35249
and dimer, in equilibrium, 4 * 35249, calculated
35249
and tetramer, in equilibrium, 2 * 35249, calculated
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
?
x * 32466, mass spectrometry
dimer
and tetramer, in equilibrium, 2 * 35249, calculated
tetramer
4 * 35249, calculated
tetramer
and dimer, in equilibrium, 4 * 35249, calculated
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
to 1.97 A resolution, crystal structure of enzyme bound to pyruvate. Modeling of the 4-hydroxy-2-oxoglutarate-Schiff base intermediate and kinetic analyses of site-directed mutants support the importance of Lys196 as the nucleophile, Tyr168 and Ser77 as components of a proton relay, and Asn78 and Ser198 as unique residues that facilitate substrate binding
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
C257G
natural mutation associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
DeltaE315
natural mutation associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
G287V
natural mutation associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
K196A
complete loss of activity
N78A
20% of wild-type activity
N78Q
4% of wild-type activity
N78T
45% of wild-type activity
P190L
natural mutation associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
R255X
a truncation of 71 residues from the C-terminus associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
R303C
natural mutation associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
R70P
natural mutation associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
R97C
natural mutation associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
S198A
9% of wild-type activity
S198T
18% of wild-type activity
S77A
5% of wild-type activity
S77T
2% of wild-type activity
S77V
2% of wild-type activity
T280I
natural mutation associated with Primary Hyperoxaluria type 3. Mutant is quite unstable, has a tendency to aggregate, and retains no measurable activity
Y140F
122% of wild-type activity
Y168F
complete loss of activity
Y39X/R70X
naturally occuring mutations in a patient with type 3 atypical primary hyperoxaluria
G287V
-
the mutation is associated with primary hyperoxaluria type 3
P190L
-
the mutation is associated with primary hyperoxaluria type 3
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
expressed in Escherichia coli BL21 (DE3) cells and HEK-293 cells
expression in Escherichia coli
genotyping in 28 patients with type 3 atypical primary hyperoxaluria, overview
expression in Escherichia coli
expression in Escherichia coli
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
medicine
mutations in the gene encoding for 4-hydroxy-2-oxoglutarate aldolase are associated with an excessive production of oxalate in Primary Hyperoxaluria type 3, PH3. Analysis of nine PH3 human variants reveals that all nine PH3 variants are quite unstable, have a tendency to aggregate, and retain no measurable activity. A buildup of 4-hydroxy-2-oxoglutarate takes place in the urine, sera and liver samples from PH3 patients. One hypothetical component of the molecular basis for the excessive oxalate production in PH3 appears to be the inhibition of glyoxylate reductase by 4-hydroxy-2-oxoglutarate, resulting in a phenotype similar to Primary Hyperoxaluria type 2
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Belostotsky, R.; Seboun, E.; Idelson, G.H.; Milliner, D.S.; Becker-Cohen, R.; Rinat, C.; Monico, C.G.; Feinstein, S.; Ben-Shalom, E.; Magen, D.; Weissman, I.; Charon, C.; Frishberg, Y.
Mutations in DHDPSL are responsible for primary hyperoxaluria type III
Am. J. Hum. Genet.
87
392-399
2010
Homo sapiens (Q86XE5), Homo sapiens
brenda
Riedel, T.J.; Knight, J.; Murray, M.S.; Milliner, D.S.; Holmes, R.P.; Lowther, W.T.
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition
Biochim. Biophys. Acta
1822
1544-1552
2012
Homo sapiens (Q86XE5), Homo sapiens
brenda
Riedel, T.J.; Johnson, L.C.; Knight, J.; Hantgan, R.R.; Holmes, R.P.; Lowther, W.T.
Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria
PLoS ONE
6
e26021
2011
Homo sapiens (Q86XE5), Homo sapiens
brenda
Williams, E.L.; Bockenhauer, D.; vant Hoff, W.G.; Johri, N.; Laing, C.; Sinha, M.D.; Unwin, R.; Viljoen, A.; Rumsby, G.
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3
Nephrol. Dial. Transplant.
27
3191-3195
2012
Homo sapiens (Q86XE5), Homo sapiens
brenda
MacDonald, J.R.; Huang, A.D.; Loomes, K.M.
Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3
FEBS Lett.
590
1467-1476
2016
Homo sapiens (Q86XE5)
brenda
Mdimegh, S.; Aquaviva-Bourdain, C.; Omezzine, A.; Souche, G.; Mbarek, I.; Abidi, K.; Gargah, T.; Abroug, S.; Bouslama, A.
HOGA1 gene mutations of primary hyperoxaluria type 3 in tunisian patients
J. Clin. Lab. Anal.
31
e22053
2017
Homo sapiens
brenda